| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.30B | $889.9M | $935.8M |
| YoY Revenue Growth % | +46.1% | -4.9% | — |
| Gross Profit | $429.1M | $192.1M | — |
| Gross Margin % | 33.0% | 21.6% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$399.0M | -$12.6M | -$8.6M |
| Operating Margin % | -30.7% | -1.4% | -0.9% |
| Net Income (GAAP) | -$517.1M | -$711.0K | $10.2M |
| EBITDA (Normalized) | -$394.5M | -$6.7M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $7.6M | $68.6M | $13.7M |
| Capital Expenditures (CapEx) | $5.6M | $7.4M | — |
| Free Cash Flow (FCF) | $2.0M | $61.2M | $13.7M |
| FCF Margin % | 0.2% | 6.9% | 1.5% |
| Return on Invested Capital (ROIC %) | -45.0% | -7.0% | — |
| Cash & Short-Term Equivalents | $128.2M | $89.1M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $95.4M | $231.3M | — |